Last reviewed · How we verify

NCT06601569

Predictors of Range of Motion and Balance Abnormalities in Children Diagnosed with Cerebral Palsy

Recruiting now Last updated 1 October 2024
What this trial tests

trial testing balance and range of motion in Cerebral Palsy in 120 participants. Currently enrolling.

Timeline
1 August 2024
Primary endpoint
1 January 2025
1 February 2025

Quick facts

Lead sponsorCairo University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date1 August 2024
Primary completion1 January 2025
Estimated completion1 February 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 Months to 5, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. To better understand the factors that contribute to ROM abnormalities in children diagnosed with CP. 2. To describe the distribution of primary (muscle tone and postural stability)and secondary impairments (ROM and functional muscle strength) across the gross motor spectrum measured by GMFCS scores. 3. To evaluate the effects of primary and secondary impairments on gross functional outcome in children with spastic CP. 4. To find any possible correlation between clinical variables.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06601569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing